Ticker · CUSIP 37733W204
Holders (tracked)
18
Combined shares
132,002,742
Combined value
$6.47B
Last close
$58.35
Quarter
2025Q4
Price · 1Y$58.35+23.80 (+68.89%)H $60.69 · L $34.55 · Avg Vol 5.0M
Congress buyCongress sellPosition opened
Tracked holders · last 8 quarters
+5 vs previous quarter over the last 8.
Price is +19.0% vs the avg quarter-end implied price across tracked holders.
SEC event timeline
24 events
- AQR Capital Management added2026-02-17+32,996 shares · 2025Q4Position
- +214,099 shares · 2025Q4Position
- Wellington Management added2026-02-17+9,137,167 shares · 2025Q4Position
- +29,500 shares · 2025Q4Position
- Jeremy Grantham (GMO) added2026-02-17+917,248 shares · 2025Q4Position
- D.E. Shaw & Co. opened position2026-02-17+5,544 shares · 2025Q4Position
- Two Sigma Investments trimmed2026-02-17−53,200 shares · 2025Q4Position
- Izzy Englander (Millennium Mgmt) trimmed2026-02-17−21,385 shares · 2025Q4Position
- Steve Cohen (Point72) opened position2026-02-17+1,474,951 shares · 2025Q4Position
- T. Rowe Price trimmed2026-02-17−57,283 shares · 2025Q4Position
- Dodge & Cox trimmed2026-02-13−9,885,765 shares · 2025Q4Position
- Ray Dalio (Bridgewater Associates) added2026-02-13+14,770 shares · 2025Q4Position
- Renaissance Technologies trimmed2026-02-12−952,381 shares · 2025Q4Position
- Ken Fisher (Fisher Asset Mgmt) added2026-02-09+968,370 shares · 2025Q4Position
- AQR Capital Management added2025-11-14+150,316 shares · 2025Q3Position
- T. Rowe Price trimmed2025-11-14−94,380 shares · 2025Q3Position
- Wellington Management added2025-11-14+1,965,611 shares · 2025Q3Position
- Izzy Englander (Millennium Mgmt) trimmed2025-11-14−13,437 shares · 2025Q3Position
- Ray Dalio (Bridgewater Associates) added2025-11-13+57,713 shares · 2025Q3Position
- Jeremy Grantham (GMO) trimmed2025-11-13−29,449 shares · 2025Q3Position
- Renaissance Technologies trimmed2025-11-13−262,900 shares · 2025Q3Position
- Norges Bank (Norway SWF) exited2025-11-13−55,000 shares · 2025Q3Position
- Dodge & Cox trimmed2025-11-13−354,135 shares · 2025Q3Position
- Ken Fisher (Fisher Asset Mgmt) added2025-11-12+889,210 shares · 2025Q3Position
Insider activity
No insider transactions in the last 30 days.
Follow-the-investor returns
If you'd copied each holder of GSK…
Cost basis inferred from each manager's quarter-over-quarter position changes. Sorted by % return on the position they're still holding.
| Investor | First in | Cost basis | Return | Position value today |
|---|---|---|---|---|
| T. Rowe Price | 2022Q3 | $30.95 | +88.5% | $460.7M |
| Dodge & Cox | 2022Q3 | $31.48 | +85.3% | $4.00B |
| Renaissance Technologies | 2022Q3 | $32.69 | +78.5% | $60.4M |
| Two Sigma Investments | 2022Q3 | $33.20 | +75.8% | $2.1M |
| Ken Fisher (Fisher Asset Mgmt) | 2022Q3 | $35.63 | +63.7% | $1.94B |
| Ray Dalio (Bridgewater Associates) | 2022Q3 | $36.71 | +58.9% | $82.7M |
| D.E. Shaw & Co. | 2022Q3 | $39.48 | +47.8% | $323K |
| Jeremy Grantham (GMO) | 2022Q3 | $40.52 | +44.0% | $203.6M |
| AQR Capital Management | 2024Q1 | $43.14 | +35.2% | $13.8M |
| Izzy Englander (Millennium Mgmt) | 2022Q3 | $44.03 | +32.5% | $2.5M |
| Izzy Englander (Millennium Mgmt) | 2022Q3 | $44.03 | +32.5% | $2.5M |
| Ken Griffin (Citadel Advisors) | 2022Q3 | $46.29 | +26.1% | $28.3M |
| Ken Griffin (Citadel Advisors) | 2022Q3 | $46.29 | +26.1% | $28.3M |
| Ken Griffin (Citadel Advisors) | 2022Q3 | $46.29 | +26.1% | $28.3M |
| Wellington Management | 2022Q3 | $46.64 | +25.1% | $732.7M |
| Paul Tudor Jones (Tudor Investment) | 2022Q3 | $46.84 | +24.6% | $1.5M |
| Paul Tudor Jones (Tudor Investment) | 2022Q3 | $46.84 | +24.6% | $1.5M |
| Steve Cohen (Point72) | 2022Q3 | $48.16 | +21.2% | $86.1M |
Who moved on this name in 2025Q4
Position changes reported for the latest quarter, grouped by direction.
New positions4
- Steve Cohen (Point72)+1,474,951$72.3M
- Ken Griffin (Citadel Advisors)+214,099$10.5M
- Paul Tudor Jones (Tudor Investment)+29,500$1.4M
- D.E. Shaw & Co.+5,544$272K
Added to5
- Wellington Management+9,137,167$448.1M
- Ken Fisher (Fisher Asset Mgmt)+968,370$47.5M
- Jeremy Grantham (GMO)+917,248$45.0M
- AQR Capital Management+32,996$1.6M
- Ray Dalio (Bridgewater Associates)+14,770$724K
Trimmed5
- Dodge & Cox−9,885,765$484.8M
- Renaissance Technologies−952,381$46.7M
- Two Sigma Investments−53,200$2.6M
- Izzy Englander (Millennium Mgmt)−21,385$1.0M
- T. Rowe Price−57,283$3K
Exited0
—
Institutional ownership over time
Distinct super-investors holding this ticker · combined dollar value, by quarter.
| Quarter | Holders | Combined value |
|---|---|---|
| 2022Q3 | 23 | $3.55B |
| 2022Q4 | 21 | $4.00B |
| 2023Q1 | 19 | $3.76B |
| 2023Q2 | 16 | $3.77B |
| 2023Q3 | 15 | $3.85B |
| 2023Q4 | 16 | $3.92B |
| 2024Q1 | 17 | $4.52B |
| 2024Q2 | 15 | $4.18B |
| 2024Q3 | 17 | $4.38B |
| 2024Q4 | 17 | $3.64B |
| 2025Q1 | 17 | $4.93B |
| 2025Q2 | 18 | $4.93B |
| 2025Q3 | 13 | $5.63B |
| 2025Q4 | 18 | $6.47B |
Congress members trading this stock
| Date | Member | Type | Amount range | Filing |
|---|---|---|---|---|
| 2025-10-31 | Lisa McClain | Sell | $1K – $15K | PDF ↗ |
| 2025-10-30 | Lisa McClain | Sell | $1K – $15K | PDF ↗ |
| 2025-10-30 | Lisa McClain | Buy | $1K – $15K | PDF ↗ |
| 2025-09-23 | Valerie Hoyle | Sell | $1K – $15K | PDF ↗ |
| 2025-08-04 | Lisa McClain | Buy | $1K – $15K | PDF ↗ |
| 2025-07-28 | Robert B. Aderholt | Sell | $1K – $15K | PDF ↗ |
| 2025-06-24 | Lisa McClain | Sell | $1K – $15K | PDF ↗ |
| 2025-06-17 | Lisa McClain | Buy | $1K – $15K | PDF ↗ |
| 2025-04-21 | Bruce Westerman | Sell | $1K – $15K | PDF ↗ |
| 2025-03-03 | Bruce Westerman | Buy | $1K – $15K | PDF ↗ |
| 2024-11-18 | Valerie Hoyle | Buy | $1K – $15K | PDF ↗ |
Who owns GSK
18 super-investors · 2025Q4
Tracked stake
132.00M
shares
Combined value
$6.47B
% of shares outstanding
—
shares-out unknown
Quarter action mix
New7Added5Trim6
| # | Manager | Shares | Value |
|---|---|---|---|
| 1 | Dodge & Cox | 68.52M | $3.36B |
| 2 | Ken Fisher Fisher Asset Mgmt | 33.20M | $1.63B |
| 3 | Wellington Management | 12.56M | $616M |
| 4 | T. Rowe Price | 7.89M | $387M |
| 5 | Jeremy Grantham GMO | 3.49M | $171M |
| 6 | Steve Cohen Point72 | 1.47M | $72M |
| 7 | Ray Dalio Bridgewater Associates | 1.42M | $69M |
| 8 | Renaissance Technologies | 1.04M | $51M |
| 9 | Ken Griffin Citadel Advisors | 720.1K | $35M |
| 10 | Izzy Englander Millennium Mgmt | 649.4K | $32M |
| 11 | Ken Griffin Citadel Advisors | 485.0K | $24M |
| 12 | AQR Capital Management | 236.6K | $12M |
| 13 | Ken Griffin Citadel Advisors | 214.1K | $10M |
| 14 | Izzy Englander Millennium Mgmt | 43.6K | $2M |
| 15 | Two Sigma Investments | 36.3K | $2M |
| 16 | Paul Tudor Jones Tudor Investment | 24.9K | $1M |
| 17 | D.E. Shaw & Co. | 5.5K | $272K |
| 18 | Paul Tudor Jones Tudor Investment | 4.6K | $226K |
Recent moves
20 transactions
- −21,385 · 2025Q4
- +29,500 · 2025Q4
- +1,474,951 · 2025Q4
- +214,099 · 2025Q4
- +32,996 · 2025Q4
- +917,248 · 2025Q4
- +5,544 · 2025Q4
- TRIMT. Rowe Price−57,283 · 2025Q4
- −53,200 · 2025Q4
- +9,137,167 · 2025Q4
- +14,770 · 2025Q4
- TRIMDodge & Cox−9,885,765 · 2025Q4
- −952,381 · 2025Q4
- +968,370 · 2025Q4
- +150,316 · 2025Q3
- −13,437 · 2025Q3
- TRIMT. Rowe Price−94,380 · 2025Q3
- +1,965,611 · 2025Q3
- −55,000 · 2025Q3
- −262,900 · 2025Q3
Embed this chart
Paste this iframe anywhere to embed the live GSK chart.
<iframe src="https://openstocks.me/embed/stocks/GSK" width="100%" height="480" frameborder="0" loading="lazy" title="GSK chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>Explore related topics
- GSK insider tradingEvery Form 4 filing by GSK officers, directors, and 10%+ holders.
- GSK analyst target pricesWall Street consensus target, analyst-by-analyst breakdown, and revision history.
- Most popular hedge-fund stocksSee where this ticker ranks against the broader smart-money consensus.
- All insider tradingCross-ticker view of where corporate insiders are buying on the open market.
- Congress stock tradesReal-time PTR disclosures filed under the STOCK Act.
- Smart-money signalsComposite signals where institutional, insider and Congress flows converge.